IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza reports fall in profits, sales

2:54 AM MST | January 23, 2014 | Deepti Ramesh

Lonza recorded a 44.2% fall in profits for 2013 compared with 2012, to 87 million Swiss francs ($95.7 million). Sales for 2013 decreased by 4.2%, to SF3.58 billion, due to lower sales in the water treatment business; product portfolio optimization measures; unfavorable exchange rate translation effects; weaker pharma and biotech sales in the first half of the year; and the previously announced phase down of the company’s microbial biologics plant at Hopkinton, MA, Lonza says. Core Ebit for 2013 increased by 11.2%, however, to SF436 million. In line with the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa